The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global lactase market is expected to exhibit a CAGR of 6.36% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Lactase, also known as lactase-phlorizin hydrolase, is an enzyme naturally found in yeast, fungi and the small intestines of mammals, which hydrolyzes beta(β)-galactosides into simple sugar glucose and galactose. Its deficiency in the gut can lead to the development of lactose intolerance, which results in abdominal cramping and diarrhea after ingesting milk products. Consequently, lactase is added to regular milk for preventing the symptoms of lactose intolerance and enables individuals to consume adequate amounts of milk. Lactase is also available in different dosage forms, including drops, capsules and tablets.
A significant rise in the number of individuals suffering from lactose intolerance is positively influencing the demand for lactose-free dairy products. This represents one of the key factors positively influencing the lactase demand to produce lactose-free milk products. Moreover, the growing awareness about health and wellness among individuals is promoting the adoption of lactase pills, which are taken before consuming dairy products to help ease irritable bowel syndrome (IBS) symptoms. Apart from this, as liquid lactase has better functionality and high activity, it is finding extensive application in the pharmaceutical industry for manufacturing syrups and tonics. The leading market players are also introducing new delivery forms, such as strength caplets and fast-acting chewable tablets, to prevent lactose digestion problems like gas, nausea and stomachache. Furthermore, the growing awareness among individuals about healthy digestion and proper functioning of the immune system is anticipated to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global lactase market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on source, form and application.
Breakup by Source:
Breakup by Form:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S and Polttimo Oy.
|Base Year of the Analysis||2021|
|Segment Coverage||Source, Form, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S and Polttimo Oy|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
We expect the global lactase market to exhibit a CAGR of 6.36% during 2022-2027.
The rising number of lactose-intolerant individuals, coupled with the increasing consumption of lactase
pills to ease irritable bowel syndrome (IBS) symptoms, is primarily driving the global lactase market.
The sudden outbreak of the COVID-19 pandemic has led to the changing consumer inclination from
conventional brick-and-mortar distribution channels towards online retail platforms for the purchase of
lactase in different dosage forms, including drops, capsules, tablets, etc.
Based on the source, the global lactase market can be segmented into fungi, yeast, and bacteria.
Currently, yeast holds the majority of the total market share.
Based on the form, the global lactase market has been divided into powder and liquid, where powder
currently exhibits a clear dominance in the market.
Based on the application, the global lactase market can be categorized into food and beverages, dietary
supplements, and pharmaceuticals. Among these, the food and beverage sector accounts for the largest
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global lactase market include Advanced Enzyme Technologies,
Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de
Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S, and Polttimo Oy.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at